A Phase 2b/3 randomized, double-blind, placebo-controlled, parallel group, multicentre study investigating the efficacy and safety of JNJ54861911 in subjects who are asymptomatic at risk for develo... (2016–2022)
- Grant type:
- Janssen-Cilag Pty Limited (Janssen-Cilag Australia)
- Researchers:
-
-
Mayne Professor of Psychiatry
Medical School (Office & AME)Faculty of Medicine
-
- Funded by:
- Janssen-Cilag Pty Limited (Janssen-Cilag Australia)
